{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-26-046755","form_type":"8-K","ticker":"BIAF","cik":"0001712762","company_name":"bioAffinity Technologies, Inc.","filed_at":"2026-10-13T13:23:00+00:00","discovered_at":"2026-10-13T13:24:01.215946+00:00","generated_at":"2026-10-13T13:24:11.082411+00:00","sec_items":["8.01","9.01"],"event_type":"other_material","sentiment":"positive","materiality_score":0.4,"calibrated_materiality_score":0.4,"confidence":"high","headline":"bioAffinity to present CHEST 2026 data on sputum tests for asthma and COPD lung inflammation","bullets":["bioAffinity will present poster 3071 at CHEST 2026 on Oct. 20 in Phoenix on sputum-based tests measuring lung inflammation in asthma and COPD.","Research measured targets TSLP, CRLF2, IL4-Rα (CD124) and IL-5, linked to drugs tezepelumab, verkitug, dupilumab and mepolizumab.","Sputum samples came from people with asthma, smokers with/without COPD, a smoker with both COPD and asthma, and healthy individuals; flow cytometry, ELISA and machine learning were used.","CyPath Lung, marketed as an LDT, showed 92% sensitivity, 87% specificity, 88% accuracy and 99% NPV for lung cancer in high-risk patients with nodules under 20 mm.","Global asthma therapeutics market was about $29.7 billion in 2025 and is projected to reach $47.6 billion by 2034."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-26-046755","json":"https://secwatch.observer/filing/0001493152-26-046755.json","markdown":"https://secwatch.observer/filing/0001493152-26-046755.md","text":"https://secwatch.observer/filing/0001493152-26-046755.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1712762/000149315226046755/0001493152-26-046755-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1712762/000149315226046755/form8-k.htm"},"model":{"generated_by":"deepseek-v4.1-flash:cloud@v2","generated_at":"2026-10-13T13:24:11.082411+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}